Which of the following adverse effects is associated with evinacumab?

Enhance your knowledge of antihyperlipidemics and lipid management. Study with multiple choice questions and detailed explanations. Ace your test!

Multiple Choice

Which of the following adverse effects is associated with evinacumab?

Severe hypersensitivity reactions are a known risk with monoclonal antibody therapies, and evinacumab is a human antibody directed against ANGPTL3 used for homozygous familial hypercholesterolemia. Because it is an infused antibody, there is potential for infusion-related reactions and systemic allergic reactions, including anaphylaxis. This is why severe hypersensitivity is the most notable adverse effect to be aware of with evinacumab. Drowsiness, edema, and abdominal pain are not characteristic or defining adverse effects of evinacumab. They can occur with various medicines but are not the primary safety signal associated with this drug. When monitoring a patient receiving evinacumab, the key concern is watching for signs of a hypersensitivity reaction during or after the infusion and having emergency treatment available if needed.

Severe hypersensitivity reactions are a known risk with monoclonal antibody therapies, and evinacumab is a human antibody directed against ANGPTL3 used for homozygous familial hypercholesterolemia. Because it is an infused antibody, there is potential for infusion-related reactions and systemic allergic reactions, including anaphylaxis. This is why severe hypersensitivity is the most notable adverse effect to be aware of with evinacumab.

Drowsiness, edema, and abdominal pain are not characteristic or defining adverse effects of evinacumab. They can occur with various medicines but are not the primary safety signal associated with this drug. When monitoring a patient receiving evinacumab, the key concern is watching for signs of a hypersensitivity reaction during or after the infusion and having emergency treatment available if needed.

More practice questions